Table I.
Association between serum miR-204-5p expression and the different clinicopathological features of the endometrial cancer samples.
| Clinical serum sample | |||
|---|---|---|---|
|
|
|||
| Variable | n | miR-204-5p expression | P-value |
| Total | 52 | ||
| Age (years) | |||
| ≤50 | 11 | 2.53±2.38 | 1.86 |
| >50 | 41 | 2.67±2.24 | |
| FIGO stage | |||
| Stage I | 37 | 2.34±2.24 | 0.42 |
| Stage II | 9 | 2.05±1.96 | |
| Stage III | 6 | 1.82±1.78 | |
| Grade (endometrioid) | |||
| G1 | 27 | 2.45±2.28 | 0.44 |
| G2 | 18 | 2.12±2.05 | |
| G3 | 7 | 1.88±1.82 | |
| Myometrial invasion | |||
| <1/2 | 40 | 2.48±2.32 | 0.12 |
| ≥1/2 | 12 | 1.96±1.85 | |
| Lymph node metastasis | |||
| Negative | 47 | 2.57±2.36 | <0.001 |
| Positive | 5 | 0.17±0.03 | |